The Effect of CoQ10 Administration on Hemodialysis Patients

• Status: Completed
• Trial end date: 2004-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine whether CoQ10 administration is effective as an antioxidant in hemodialysis patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Shizuoka
• Treatments: Coenzyme Q10; Ubiquinone

Criteria

Inclusion Criteria:

• hemodialysis for at least 6 months

Exclusion Criteria:

• none